SubGenual CG25 Deep Brain Stimulation in Severe Resistant Depression (CG25)
Subgenual Cingulate Stimulation in Resistant Depression
Despite the availability of several treatments, a number of patients with major depression are refractory to therapeutical approaches and therefore suffer from chronic handicap. For these severe patients, neurosurgical therapies can be envisaged. They aim at interrupting bundles that link the orbitofrontal cortex with striatum and can therefore benefit for the patients.
This study intends to repeat Dr. Lozano's study, published in 2005 in the journal Neuron. In this study, they performed a preliminary evaluation of chronic deep brain stimulation (DBS) of the subgenual cingulate region (Brodmann area 25) to treat refractory depression as an alternative to subcaudate tractotomy. This last technique was employed in Grenoble in the 60s with satisfying results before neurosurgery for psychiatric disorders was abandoned. Since 1992, psychosurgical therapies that respect ethical recommendations have regained interest to treat highly impaired patients. Before the investigators can propose deep brain stimulation of subgenual cingulate brain region as a new therapeutic approach for the investigators patients in Grenoble, the investigators decided to reproduce their clinical evaluation on a group of 6 patients, repeating their methodology faithfully. Therefore nothing was changed to the model used by Drs. Lozano and Mayberg and the investigators took advantage of the investigators own expertise regarding deep brain stimulation and subcaudate tractotomy.
Protocol is strictly identical to the one of Mayberg and Lozano in order to confirm their preliminary results. Cartography of physiological consequences of this procedure will be assessed by measuring cerebral blood flow by PET scan (positron emission tomography). Patients will be monitored and thoroughly assessed during including psychiatric, neurological, neurosurgical, neuropsychological and PET scan exams to measure treatment efficacy and potential adverse reactions. Patients will be followed for two more years to assess medium-term complications. This study will be a first step toward further research including potentially a multicentric clinical trial.
研究概览
地位
条件
详细说明
The protocol involves assessment of effects of CG25 (subgenual cingulate area-Brodmann 25) DBS on mood, anxiety, apathy, anhedonia, psychomotor retardation, functional state as well as safety and tolerance by specific psychometric scores.
Moreover the protocol aims at highlighting the neurocircuits modulated by CG25 DBS by means of PET (positron emission tomography) imagery
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Grenoble、法国、38043
- Neurosurgery department
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion criteria:
- Men and women between 30 and 55 years old
- Women at a reproductive age will have to be under successful contraceptive and will undergo a pregnancy test before inclusion
- Patient suffering from major unipolar depression refractory to conventional therapies
- Chronic depression with ongoing depressive episode > 12 months.
- 4 unsuccessful therapies attempted to treat the ongoing episode, including anti-depressant monotherapies, potentialisation of antidepressant treatments, validated structured psychotherapies, electro-convulsive therapy performed accordingly to ANAES ( Agence Nationale d'Accréditation et d'Evaluation en Santé-the French Health Authority) recommendations (at least 6 sessions with bilateral technique and length control of convulsive crisis).
- Ambulatory or hospital care
- Able to speak French, understand study procedures and complete questionnaires.
- Covered by french social health system
- Living in Rhone-Alpes area without plan to move in the next 2 years
Exclusion criteria:
- History of cerebral surgery
- Neurological disorder that can interfere with evaluation of surgical procedure or significant cognitive impairment (Mattis score < 30)
- Psychiatric disorder responsible for comorbidity with the major depressive episode (schizophrenia and other delirium, diagnosed anxiety except generalized anxiety disorder, substance dependency)
- Personality disorder of A and B clusters
- Suicidal ideas at evaluation, intention for auto-destruction, repeated suicidal attempts in the last 3 years with emergency care or hospitalization
- Severe somatic pathology or contraindication to surgery due to heart defibrillator/pacemaker or other implanted device.
- A decrease superior to or equal to 20% in the 17-Hamilton Depression Rating Scale score between inclusion and pre-surgery evaluation
- Drug dependency including alcohol in the last 12 months with history of abuse in the last 6 months, with the exception of nicotine
- Persons protected by the law.
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
---|---|
Change from Baseline of the Score at the Hamilton Depression Rating Scale
大体时间:baseline, at 1 year
|
baseline, at 1 year
|
次要结果测量
结果测量 |
大体时间 |
---|---|
neurological examination
大体时间:monthly during the first 6 mo and every 3 months until the end of the 1st year
|
monthly during the first 6 mo and every 3 months until the end of the 1st year
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Functional outcome and health status measured by Short Form Health Survey (SF-36) scale
大体时间:at baseline, at 3 months, 12 months, 24 months
|
SF-36 scale assesses both physical and mental health status.
|
at baseline, at 3 months, 12 months, 24 months
|
合作者和调查者
调查人员
- 首席研究员:Stephan CHABARDES, MD, PhD、University Hospital, Grenoble
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.